CONTRACT RESEARCH ORGANIZATIONS (CRO)
The demand for CRO services is driven by small and medium sized pharma companies, as 60-80% of the intellectual property (IP) resides within these companies. Thus, contract research organizations need to build solutions that are low in cost with the minimal infrastructure footprint and generating quick ROI.
Larger pharma companies are focusing on long-term strategic alliances or one-stop-shops boasting broad service offerings that include non-traditional capabilities such as health economics and outcomes research (HEOR), market access, and pharmacovigilance.
However, large pharma companies will develop alliances with CROs that have end-to-end capabilities (IT+ Science).
HCL has the expertise in key functional areas, and provides the following CRO services as listed below:
Unique solutions for market access and patient recruitment and retention
HCL’s 3i framework, which can integrate the three stages of information, intelligence and interaction to motivate patients to adhere to therapy
Implementation, ASM, system validation, case processing, and aggregate reporting services
eClinical and transformational consulting, and unique transformation solutions aimed at enabling CROs offer cost competitive and improved services to their sponsors
For more information, write to us at: firstname.lastname@example.org